Press Esc to close
Lipitor, Atorvaliq, Caduet
Statin • HMG-CoA reductase inhibitor
PremiumCompetitively inhibits HMG-CoA reductase, reducing cholesterol synthesis
From the drug index — may include conditions studied rather than approved indications
4 curated · 4 major or contraindicated · select a row for management
| Interacting drug | Severity | Effect |
|---|---|---|
| clarithromycin | major | Increased myopathy risk, though less than simvastatin |
| cyclosporine | major | High risk of myopathy and rhabdomyolysis |
| ketoconazole | major | Elevated risk of myopathy and rhabdomyolysis. |
| rifampicin | major | Marked reduction in statin efficacy; loss of lipid-lowering effect. |
Additive hepatotoxicity risk with heavy alcohol use
Not recorded for Atorvastatin. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.
Assembled from: drug index, curated drug database, curated interaction pairs.
